Wearable diagnostics are poised to transform subjective, episodic measures of disease progression to quantified, continuous data streams, according to some industry experts.

I'm Ryan Weispfenning, vice president and head of Medtronic investor relations, and I appreciate that you're joining us for ...

If you want to monitor your vital signs like an Olympic athlete, you should welcome a pact between glucose-monitor vendor ...

Dexcom (Nasdaq:DXCM) announced today that it entered into a strategic partnership with Oura, maker of leading smart ring ...

DexCom (DXCM) and OURA, maker of the world’s leading smart ring, announced a strategic partnership to help millions of people improve their ...

DexCom invests $75M in Finnish health tech firm ŌURA, forming a strategic partnership to integrate glucose data with vital signs and biometrics.

Diabetes care device developer Dexcom and ŌURA, maker of the Oura smart ring, have announced a strategic partnership that aim ...

Smart ring company Oura announced it received $75 million in funding from glucose monitoring and diagnostics company Dexcom.

Smart ring maker Oura Health Oy is getting a $75 million investment from medical device firm Dexcom Inc., setting the stage for the two companies to share data and cross-sell products.

Medical device maker Dexcom said on Tuesday it will invest $75 million in Ōura's latest funding round, valuing the smart ring maker at over $5 billion.